A Balancing Act: Immunosuppression in Transplant Medicine

Hear stories from real patients in this replay from a live CME Outfitters symposium, as nationally-renowned experts, Flavio G. Vincenti, MD, and Lewis W. Teperman, MD, FACS, present the latest evidence on antibody-mediated complications, regular monitoring strategies to optimize immunosuppression, & engaging patients in discussions to promote adherence and improve patient outcomes.

 

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Saturday, July 15, 2017

Faculty

 

Flavio G. Vincenti, MD Flavio G. Vincenti, MD
Professor of Clinical Medicine and Surgery
Medical Director, Kidney-Pancreas Program
University of California San Francisco
San Francisco, CA

 

Lewis W. Teperman, MD FACS Lewis W. Teperman, MD FACS
Vice Chairman of Surgery
Director of Transplantation
Director, Northwell Health System Transplant Center
Manhasset NY
Professor
Hofstra University Medical School
Hempstead, NY

 

Statement of Need

The current goal of transplant medicine and immunology is to develop strategies to extend the life and functionality of every allograft. Outcomes of renal and liver transplantation have improved; yet, allograft loss remains a substantial problem associated with increased morbidity, mortality, and costs.1 Identifying the pathologic pathways responsible for allograft loss and developing therapeutic interventions is one of the primary challenges in transplant medicine.

Education to transplant clinicians about regularly evaluating all of the aspects of post-transplant care that can contribute to allograft dysfunction or loss can improve the patient-provider dialogue to foster adherence to treatment and careful monitoring of medication levels to maintain quality of life. Patient stories, integrated in the symposium design, highlight the challenges and opportunities to coordinate care with patients in alignment with the priorities of the National Quality Strategy.

This CME Outfitters webcast is a replay of a 60-minute symposium featuring two expert faculty members presenting the latest evidence on antibody-mediated complications, regular monitoring strategies to optimize immunosuppression, and engaging patients in discussions to promote adherence and improve outcomes.

Reference:
Sharma S, Oliver K, Mudge DW. Advances in antibody mediated rejection. Chapter 20. In: Current Issues and Future Direction in Kidney Transplantation. InTech Open Website. http://cdn.intechopen.com/pdfs-wm/42886.pdf. Published 2013. Accessed July 15, 2016.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Describe the causes of antibody-mediated complications in kidney and liver transplants.
  • Implement regular monitoring strategies that can optimize appropriate immunosuppression while managing side effects in transplant patients.
  • Engage transplant patients to become participants in their treatment to promote adherence to medications and improve outcomes.

The following learning objectives pertain only to those requesting CNE credit:

  • Determine the causes of antibody-mediated complications in kidney and liver transplants.
  • Identify regular monitoring strategies that can optimize appropriate immunosuppression while managing side effects in transplant patients.
  • Describe ways to engage transplant patients to become participants in their treatment to promote adherence to medications and improve outcomes.

Financial Support

Supported by an educational grant from Novartis Pharmaceuticals Corporation

Target Audience

Transplant physicians, physician assistants, nurse practitioners, nurses, and pharmacists

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1 contact hour

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.25 contact hour of pharmacotherapeutic contact hours.

CPE Credit (Pharmacists):
ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.25 contact hours (0.125 CEUs)

Universal Activity Number: 0376-0000-16-019-H01-P

Type: knowledge-based

Successful completion of this CE activity includes participating in the live activity, reviewing the course materials, within 30 days of completion of the activity, and completing your activity evaluation and post-test online (75% pass rate required). You may print your certificate or statement of credit immediately. Please visit www.CMEOutfitters.com/20148(requires free account activation).

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Flavio Vincenti, MD has disclosed that he receives research support from Alexion; Bristol-Myers Squibb Company; Genentech, Inc.; Immucor; and Novartis Pharmaceuticals Corporation

Lewis W. Teperman, MD FACS has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to Disclose

Jeff Helfand, DO, MS (peer reviewer) has no disclosures to report.

Kimberley Murray, RN, MS (peer reviewer) has no disclosures to report.

Robert Kennedy (planning committee) has no disclosures to report.

Sharon Tordoff, CCMEP (planning committee) has no disclosures to report.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS(877.263.7767).